Oct. 28, 2024 — Medtronic, a global leader in medical technology, today announced the appointment of Dr. Matthew Kroh as the Chief Medical Officer (CMO) for Advanced Surgical Technologies and General Surgical Technologies, underscoring the company’s commitment to advancing surgical innovation and improving patient outcomes..

2024年10月28日，全球医疗技术领导者美敦力（Medtronic）今天宣布任命马修·克罗（Matthew Kroh）博士为高级外科技术和普通外科技术的首席医疗官（CMO），强调公司致力于推进外科创新和改善患者预后。。

A board-certified general surgeon with fellowship training in advanced laparoscopic and bariatric surgery and surgical endoscopy, Dr. Kroh brings extensive clinical and healthcare leadership experience to Medtronic, guiding the new product development and commercialization strategies within the Surgical business.

Kroh博士是一名获得董事会认证的普通外科医生，曾接受过高级腹腔镜和减肥手术以及外科内窥镜检查方面的奖学金培训，为美敦力带来了广泛的临床和医疗领导经验，指导了外科业务中的新产品开发和商业化战略。

Under his leadership, Medtronic aims to deepen its clinical insights and enhance its engagement with physicians and medical societies globally..

在他的领导下，美敦力旨在深化其临床见解，并加强与全球医生和医学协会的联系。。

'We are excited to welcome Dr. Kroh to Medtronic and to add his expertise, passion, and innovative spirit to our business,' said Justin Roberts, general manager and vice president of Advanced Surgical Technologies within the Surgical business, part of the Medical Surgical Portfolio at Medtronic. 'His experience in pioneering surgical innovation will be invaluable as we continue to push the boundaries of what's possible in medical technology.'.

“我们很高兴欢迎克罗博士来到美敦力，并为我们的业务增添专业知识、激情和创新精神，”美敦力医疗外科投资组合的一部分外科业务高级外科技术总经理兼副总裁贾斯汀·罗伯茨（JustinRoberts）说他在开创外科创新方面的经验将是无价的，因为我们将继续推动医疗技术的发展。”。

Dr. Kroh, currently Division Chief for Foregut and Surgical Endoscopy at the Cleveland Clinic, is a respected leader in surgical research and innovation with vast experience in early-phase clinical trials and various contributions to the development of minimally invasive surgical techniques, including robotics and single-incision laparoscopic surgery.

Kroh博士现任克利夫兰诊所前肠和外科内窥镜检查科科长，是外科研究和创新领域备受尊敬的领导者，在早期临床试验方面拥有丰富经验，并为微创外科技术的发展做出了各种贡献，包括机器人技术和单切口腹腔镜手术。

Dr. Kroh is a member of several esteemed scientific committees and has authored over 175 peer-reviewed articles..

克罗博士是几个受人尊敬的科学委员会的成员，撰写了175多篇同行评议的文章。。

'I am honored to join Medtronic, a company renowned for its dedication to transforming healthcare through innovation,' stated Dr. Kroh. 'I look forward to contributing to the development of surgical technologies that can broaden access and improve outcomes for patients worldwide.'

克罗博士说：“我很荣幸加入美敦力，这家公司以致力于通过创新改变医疗保健而闻名。”我期待着为外科技术的发展做出贡献，这些技术可以扩大全球患者的准入范围并改善预后。”

In his new role, Dr. Kroh will continue to practice surgery at the Cleveland Clinic, ensuring he remains at the forefront of clinical practice and innovation.

在他的新角色中，克罗博士将继续在克利夫兰诊所进行外科手术，确保他保持在临床实践和创新的前沿。

This appointment emphasizes the company’s strategy of combining top medical expertise with cutting-edge innovation in addressing the changing needs of both clinicians and patients.

这项任命强调了该公司将顶级医学专业知识与前沿创新相结合的战略，以满足临床医生和患者不断变化的需求。

About Medtronic

关于美敦力

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries.

大胆思考。更大胆的行动。我们是美敦力。总部位于爱尔兰戈尔韦的美敦力公司是全球领先的医疗保健技术公司，通过寻找和寻找解决方案，大胆应对人类面临的最具挑战性的健康问题。我们的使命是减轻痛苦，恢复健康，延长生命，我们将150多个国家的95000多名充满激情的全球团队团结在一起。

Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day.

我们的技术和疗法治疗70种健康状况，包括心脏设备、手术机器人、胰岛素泵、手术工具、患者监测系统等。凭借我们丰富的知识、永不满足的好奇心以及帮助所有需要帮助的人的愿望，我们提供了创新技术，每秒钟、每小时、每天都在改变两个人的生活。

Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow on LinkedIn..

随着我们增强洞察力驱动的护理、以人为本的体验以及为我们的世界带来更好的结果，对我们的期望会更高。在我们所做的每件事中，我们都在创造非凡。。。

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

任何前瞻性声明都会受到风险和不确定性的影响，例如美敦力向美国证券交易委员会提交的定期报告中所述的风险和不确定性。实际结果可能与预期结果存在重大差异。

Contacts:

联系人：

Martha Acevedo

玛莎·阿塞维多

Public Relations

公共关系

+1-786-574-0493

+1-786-574-0493

Ryan Weispfenning

瑞安·韦斯芬宁

Investor Relations

投资者关系

+1-763-505-4626

+1-763-505-4626